Multivalent delivery of immune modulators by liposomal spherical nucleic acids for… Grant US-11957788-B2 United States of America 16 Apr 2024
Alpha polyglutamated pemetrexed and uses thereof Grant US-11779584-B2 United States of America 10 Oct 2023
Gamma polyglutamated lometrexol and uses thereof Grant US-11771700-B2 United States of America 03 Oct 2023
Alpha polyglutamated pralatrexate and uses thereof Grant US-11730738-B2 United States of America 22 Aug 2023
Polyglutamated antifolates and uses thereof Grant US-11701432-B2 United States of America 18 Jul 2023
Targeted delivery of therapeutic agents to human adipocytes Grant US-11690804-B2 United States of America 04 Jul 2023
Polyglutamated antifolates and uses thereof Grant US-11534498-B2 United States of America 27 Dec 2022
Adoptive cell therapy using spherical nucleic acids (SNAs) Grant US-11433131-B2 United States of America 06 Sep 2022
Methods for treating pancreatic cancer using combination therapies Grant US-11369597-B2 United States of America 28 Jun 2022
Alpha polyglutamated antifolates and uses thereof Grant US-11344628-B2 United States of America 31 May 2022
Methods for treating metastatic pancreatic cancer using combination therapies comprising… Grant US-11344552-B2 United States of America 31 May 2022
Nanoliposomal irinotecan for use in treating small cell lung cancer Grant US-11318131-B2 United States of America 03 May 2022
Multivalent delivery of immune modulators by liposomal spherical nucleic acids for… Grant US-11123294-B2 United States of America 21 Sep 2021
Treating gastric cancer using combination therapies comprising liposomal irinotecan… Grant US-11071726-B2 United States of America 27 Jul 2021
Stabilizing camptothecin pharmaceutical compositions Grant US-10993914-B2 United States of America 04 May 2021
Methods for treating pancreatic cancer using combination therapies comprising liposomal… Grant US-10980795-B2 United States of America 20 Apr 2021
A LIPOSOME SYSTEM COMPRISING A LIPID, AN ACTIVE COMPOUND AND A VECTOR PEPTIDE Application WO-2021058463-A1 World Intellectual Property Organisation (WIPO) 01 Apr 2021
TARGETED DELIVERY OF THERAPEUTIC AGENTS TO HUMAN ADIPOCYTES Application WO-2020010059-A1 World Intellectual Property Organisation (WIPO) 09 Jan 2020